• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: this medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original PMA or panel track supplement and may not represent the most recent labeling.
 
DeviceX-PRESS 6 FRENCH VASCULAR CLOSURE SYSTEM
Generic NameDevice, hemostasis, vascular
ApplicantSt. Jude Medical, Inc.
6500 WEDGWOOD RD.
MAPLE GROVE, MN 55311
PMA NumberP020035
Date Received09/03/2002
Decision Date09/30/2003
Withdrawal Date 11/04/2010
Product Code MGB 
Docket Number 09M-0406
Notice Date 09/25/2009
Advisory Committee Cardiovascular
Expedited Review Granted? No
Combination ProductNo
Approval Order Statement  
APPROVAL FOR THE X-PRESS 6 FRENCH VASCULAR CLOSURE SYSTEM. THE DEVICE IS INDICATED FOR THE PERCUTANEOUS DELIVERY OF SUTURE FOR CLOSING THE COMMON FEMORAL ARTERY ACCESS SITE OF PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC OR INTERVENTIONAL CATHETERIZATION PROCEDURES USING SHEATHS LESS THAN OR EQUAL TO 6 FRENCH IN SIZE. THE DEVICE IS INTENDED TO REDUCE THE TIME TO HEMOSTASIS, TIME TO AMBULATION (100 FEET), AND TIME TO DISCHARGEABILITY IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC OR INTERVENTIONAL CARDIAC CATHETERIZATION PROCEDURES WITHOUT COMPLICATING CLINICAL CONDITIONS, INCLUDING THOSE PATIENTS RECEIVING GLYCOPROTEIN IIB/IIIA INHIBITORS.
Approval OrderApproval Order
SummarySummary of Safety and Effectiveness
LabelingLabeling
Supplements:  S001 S002 
-
-